Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Avgi Tsolou, Dimitrios Koparanis, Ioannis Lamprou, Alexandra Giatromanolaki & Michael I. Koukourakis. (2023) Increased glucose influx and glycogenesis in lung cancer cells surviving after irradiation. International Journal of Radiation Biology 99:4, pages 692-701.
Read now
Read now
Xiao-Lin Wang, Shi-Chun Lu, Chao Sun, Wei-Guo Jin, Yi-Wei Fan, Yu-Sheng Shu, Hong-Can Shi & Ling-Feng Min. (2021) Tripartite motif protein 11 (TRIM11), an oncogene for human lung cancer via the DUSP6-mediated ERK1/2 signaling pathway. Cancer Biology & Therapy 22:4, pages 324-332.
Read now
Read now
Ying Chu, Yi Chang, Wei Lu, Xiumei Sheng, Shengjun Wang, Huaxi Xu & Jie Ma. (2020) Regulation of Autophagy by Glycolysis in Cancer. Cancer Management and Research 12, pages 13259-13271.
Read now
Read now
Hongge Liang, Di Ma, Yan Xu, Jing Zhao, Minjiang Chen, Xiaoyan Liu, Wei Zhong, Junling Li & Mengzhao Wang. (2019) Elevated levels of pre-treatment lactate dehydrogenase are an unfavorable predictor factor in patients with EML4-ALK rearrangement non-small cell lung cancer treated with crizotinib. Cancer Management and Research 11, pages 8191-8200.
Read now
Read now
Wei Zhao, Wancheng Li, Wenjing Dai, Na Huang & Jing Qiu. (2018) LINK-A promotes cell proliferation through the regulation of aerobic glycolysis in non-small-cell lung cancer. OncoTargets and Therapy 11, pages 6071-6080.
Read now
Read now
Sarah A. Best & Kate D. Sutherland. (2018) “Keaping” a lid on lung cancer: the Keap1-Nrf2 pathway. Cell Cycle 17:14, pages 1696-1707.
Read now
Read now
Articles from other publishers (40)
Somayeh Hashemi Sheikhshabani, Paratoo Modarres, Soudeh Ghafouri‐Fard, Zeinab Amini‐Farsani, Lavin Khodaee, Nasibeh Shaygan, Zahra Amini‐Farsani & Mir Davood Omrani. (2024) Meta‐analysis of microarray data to determine gene indicators involved in cisplatin resistance in non‐small cell lung cancer. Cancer Reports 7:2.
Crossref
Crossref
Ana Silva, Mónica Costa Cerqueira, Beatriz Rosa, Catarina Sobral, Filipa Pinto-Ribeiro, Marta Freitas Costa, Fátima Baltazar & Julieta Afonso. (2023) Prognostic Value of Monocarboxylate Transporter 1 Overexpression in Cancer: A Systematic Review. International Journal of Molecular Sciences 24:6, pages 5141.
Crossref
Crossref
Yu-Shun Lin, Yen-Chu Chen, Tzu-En Chen, Mei-Ling Cheng, Ke-Shiuan Lynn, Pramod Shah, Jin-Shing Chen & Rwei-Fen S. Huang. (2022) Probing Folate-Responsive and Stage-Sensitive Metabolomics and Transcriptional Co-Expression Network Markers to Predict Prognosis of Non-Small Cell Lung Cancer Patients. Nutrients 15:1, pages 3.
Crossref
Crossref
Jia-Qi Xu, Yan-Li Fu, Jing Zhang, Kai-Yu Zhang, Jie Ma, Jing-Yi Tang, Zhi-Wei Zhang & Zhong-Yan Zhou. (2022) Targeting glycolysis in non-small cell lung cancer: Promises and challenges. Frontiers in Pharmacology 13.
Crossref
Crossref
Cole D Davidson, Jennifer A Tomczak, Eyal Amiel & Frances E Carr. (2022) Inhibition of Glycogen Metabolism Induces Reactive Oxygen Species-Dependent Cytotoxicity in Anaplastic Thyroid Cancer in Female Mice. Endocrinology 163:12.
Crossref
Crossref
Xiaotong Chen, Yunshuo Zhao, Chuanjie He, Guanfei Gao, Jiao Li, Lu Qiu, Xiaoxi Wang, Yanfeng Gao, Yuanming Qi, Kai Sun & Jiangfeng Du. (2022) Identification of a novel GLUT1 inhibitor with in vitro and in vivo anti-tumor activity. International Journal of Biological Macromolecules 216, pages 768-778.
Crossref
Crossref
Natarajaseenivasan Suriya Muthukumaran, Prema Velusamy, Charles Solomon Akino Mercy, Dianne Langford, Kalimuthusamy Natarajaseenivasan & Santhanam Shanmughapriya. (2022) MicroRNAs as Regulators of Cancer Cell Energy Metabolism. Journal of Personalized Medicine 12:8, pages 1329.
Crossref
Crossref
Jing Li, Yun Guan, Rongrong Zhu, Yang Wang, Huaguang Zhu & Xin Wang. (2022) Identification of metabolic genes for the prediction of prognosis and tumor microenvironment infiltration in early-stage non-small cell lung cancer. Open Life Sciences 17:1, pages 881-892.
Crossref
Crossref
Wei Meng, Yanli Li, Binshu Chai, Xiaomin Liu & Zhongliang Ma. (2022) miR-199a: A Tumor Suppressor with Noncoding RNA Network and Therapeutic Candidate in Lung Cancer. International Journal of Molecular Sciences 23:15, pages 8518.
Crossref
Crossref
Philippe Icard, Luca Simula, Ludovic Fournel, Karen Leroy, Audrey Lupo, Diane Damotte, Marie Christine Charpentier, Catherine Durdux, Mauro Loi, Olivier Schussler, Guillaume Chassagnon, Antoine Coquerel, Hubert Lincet, Vincent De Pauw & Marco Alifano. (2022) The strategic roles of four enzymes in the interconnection between metabolism and oncogene activation in non-small cell lung cancer: Therapeutic implications. Drug Resistance Updates 63, pages 100852.
Crossref
Crossref
Ioannis M. Koukourakis, Alexandra Giatromanolaki, Achilleas Mitrakas & Michael I. Koukourakis. (2022) Loss of HLA-class-I expression in non-small-cell lung cancer: Association with prognosis and anaerobic metabolism. Cellular Immunology 373, pages 104495.
Crossref
Crossref
Guihua Zhang, Rong Dong, Demiao Kong, Bo Liu, Yan Zha & Meng Luo. (2022) The Effect of GLUT1 on the Survival Rate and Immune Cell Infiltration of Lung Adenocarcinoma and Squamous Cell Carcinoma: A Meta and Bioinformatics Analysis. Anti-Cancer Agents in Medicinal Chemistry 22:2, pages 223-238.
Crossref
Crossref
Alexandra Giatromanolaki, Adrian L. Harris & Michael I. Koukourakis. (2021) The prognostic and therapeutic implications of distinct patterns of argininosuccinate synthase 1 (ASS1) and arginase-2 (ARG2) expression by cancer cells and tumor stroma in non-small-cell lung cancer. Cancer & Metabolism 9:1.
Crossref
Crossref
Alexandre Vallée, Yves Lecarpentier & Jean-Noël Vallée. (2021) The Key Role of the WNT/β-Catenin Pathway in Metabolic Reprogramming in Cancers under Normoxic Conditions. Cancers 13:21, pages 5557.
Crossref
Crossref
Xiaotong Chen, Yunshuo Zhao, Sifan Lyu, Guanfei Gao, Yanfeng Gao, Yuanming Qi & Jiangfeng Du. (2021) Identification of novel inhibitors of GLUT1 by virtual screening and cell-based assays. Investigational New Drugs 39:5, pages 1242-1255.
Crossref
Crossref
Lyudmila Krassikova, Boxi Zhang, Divya Nagarajan, André Lima Queiroz, Merve Kacal, Evangelos Samakidis, Helin Vakifahmetoglu-Norberg & Erik Norberg. (2020) The deubiquitinase JOSD2 is a positive regulator of glucose metabolism. Cell Death & Differentiation 28:3, pages 1091-1109.
Crossref
Crossref
Xiangli Liu, Lidan Liu, Keyan Chen, Lei Sun, Wenya Li & Shuguang Zhang. (2020) Huaier shows anti‐cancer activities by inhibition of cell growth, migration and energy metabolism in lung cancer through PI3K/AKT/HIF‐1α pathway. Journal of Cellular and Molecular Medicine 25:4, pages 2228-2237.
Crossref
Crossref
Xiufeng Jiang, Wei Zhao, Feng Zhu, Hui Wu, Xiao Ding, Jinmei Bai, Xiaoqing Zhang & Meifang Qian. (2021) Ligustilide inhibits the proliferation of non-small cell lung cancer via glycolytic metabolism. Toxicology and Applied Pharmacology 410, pages 115336.
Crossref
Crossref
D. A. Richardson, P. Sritangos, A. D. James, A. Sultan & J. I. E. Bruce. (2020) Metabolic regulation of calcium pumps in pancreatic cancer: role of phosphofructokinase-fructose-bisphosphatase-3 (PFKFB3). Cancer & Metabolism 8:1.
Crossref
Crossref
Alexandra Giatromanolaki, Avgi Tsolou, Eleftheria Daridou, Maria Kouroupi, Katerina Chlichlia & Michael I. Koukourakis. (2020) iNOS Expression by Tumor-Infiltrating Lymphocytes, PD-L1 and Prognosis in Non-Small-Cell Lung Cancer. Cancers 12:11, pages 3276.
Crossref
Crossref
Alexandra Giatromanolaki, Maria Kouroupi, Stamatia Pouliliou, Achilleas Mitrakas, Fatma Hasan, Aglaia Pappa & Michael I. Koukourakis. (2020) Ectonucleotidase CD73 and CD39 expression in non-small cell lung cancer relates to hypoxia and immunosuppressive pathways. Life Sciences 259, pages 118389.
Crossref
Crossref
Choong-Hwan Kwak, Ling Jin, Jung Ho Han, Chang Woo Han, Eonmi Kim, MyoungLae Cho, Tae-Wook Chung, Sung-Jin Bae, Se Bok Jang & Ki-Tae Ha. (2020) Ilimaquinone Induces the Apoptotic Cell Death of Cancer Cells by Reducing Pyruvate Dehydrogenase Kinase 1 Activity. International Journal of Molecular Sciences 21:17, pages 6021.
Crossref
Crossref
Jon Sánchez-Valle, Héctor Tejero, José María Fernández, David Juan, Beatriz Urda-García, Salvador Capella-Gutiérrez, Fátima Al-Shahrour, Rafael Tabarés-Seisdedos, Anaïs Baudot, Vera Pancaldi & Alfonso Valencia. (2020) Interpreting molecular similarity between patients as a determinant of disease comorbidity relationships. Nature Communications 11:1.
Crossref
Crossref
Sabah Nisar, Sheema Hashem, Muzafar A. Macha, Santosh K. Yadav, Sankavi Muralitharan, Lubna Therachiyil, Geetanjali Sageena, Hamda Al-Naemi, Mohammad Haris & Ajaz A. Bhat. (2020) Exploring Dysregulated Signaling Pathways in Cancer. Current Pharmaceutical Design 26:4, pages 429-445.
Crossref
Crossref
Torsten Müller, Mathias Kalxdorf, Rémi Longuespée, Daniel N Kazdal, Albrecht Stenzinger & Jeroen Krijgsveld. (2020)
Automated sample preparation with
SP
3 for low‐input clinical proteomics
. Molecular Systems Biology 16:1.
Crossref
Crossref
Shangnan Dai, Yunpeng Peng, Yi Zhu, Dalai Xu, Feng Zhu, Wenbin Xu, Qiuyang Chen, Xiaole Zhu, Tongtai Liu, Chaoqun Hou, Junli Wu & Yi Miao. (2020) Glycolysis promotes the progression of pancreatic cancer and reduces cancer cell sensitivity to gemcitabine. Biomedicine & Pharmacotherapy 121, pages 109521.
Crossref
Crossref
Gebing Yao, Jikai Yin, Qing Wang, Rui Dong & Jianguo Lu. (2019) Glypican-3 Enhances Reprogramming of Glucose Metabolism in Liver Cancer Cells. BioMed Research International 2019, pages 1-11.
Crossref
Crossref
Jiang Shi, Huan Wang, Wanlu Feng, Siyuan Huang, Jinlu An, Yajuan Qiu & Kai Wu. (2019) Long non-coding RNA HOTTIP promotes hypoxia-induced glycolysis through targeting miR-615-3p/HMGB3 axis in non-small cell lung cancer cells. European Journal of Pharmacology 862, pages 172615.
Crossref
Crossref
Gang Zhao. (2019) Functions of metabolic enzymes in the development of non‐small cell lung cancer. Thoracic Cancer 10:9, pages 1744-1747.
Crossref
Crossref
Alexandra Giatromanolaki, Ioannis M. Koukourakis, Konstantina Balaska, Achilleas G. Mitrakas, Adrian L. Harris & Michael I. Koukourakis. (2019) Programmed death-1 receptor (PD-1) and PD-ligand-1 (PD-L1) expression in non-small cell lung cancer and the immune-suppressive effect of anaerobic glycolysis. Medical Oncology 36:9.
Crossref
Crossref
Marrugal, Ferrer, Pastor, Ojeda, Quintanal-Villalonga, Carnero, Molina-Pinelo & Paz-Ares. (2019) Impact of Heat Shock Protein 90 Inhibition on the Proteomic Profile of Lung Adenocarcinoma as Measured by Two-Dimensional Electrophoresis Coupled with Mass Spectrometry. Cells 8:8, pages 806.
Crossref
Crossref
Angara Zambrano, Matías Molt, Elena Uribe & Mónica Salas. (2019) Glut 1 in Cancer Cells and the Inhibitory Action of Resveratrol as A Potential Therapeutic Strategy. International Journal of Molecular Sciences 20:13, pages 3374.
Crossref
Crossref
Julieta Afonso, Tatiana Pinto, Susana Simões-Sousa, Fernando Schmitt, Adhemar Longatto-Filho, Céline Pinheiro, Herlander Marques & Fátima Baltazar. (2019) Clinical significance of metabolism-related biomarkers in non-Hodgkin lymphoma – MCT1 as potential target in diffuse large B cell lymphoma. Cellular Oncology 42:3, pages 303-318.
Crossref
Crossref
Lin Jin & Yanhong Zhou. (2019) Crucial role of the pentose phosphate pathway in malignant tumors (Review). Oncology Letters.
Crossref
Crossref
Bo Zhang, Zhaodi Xie & Bin Li. (2019) The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis. Gene 689, pages 76-83.
Crossref
Crossref
Tereza Golias, Martin Kery, Silvia Radenkovic & Ioanna Papandreou. (2018) Microenvironmental control of glucose metabolism in tumors by regulation of pyruvate dehydrogenase. International Journal of Cancer 144:4, pages 674-686.
Crossref
Crossref
Ziyan Zhao, Rahul Rajagopalan & Adam Zweifach. (2018) A Novel Multiple-Read Screen for Metabolically Active Compounds Based on a Genetically Encoded FRET Sensor for ATP. SLAS Discovery 23:9, pages 907-918.
Crossref
Crossref
Katarzyna Zabłocka-Słowińska, Sylwia Płaczkowska, Anna Prescha, Konrad Pawełczyk, Monika Kosacka, Irena Porębska & Halina Grajeta. (2018) Systemic redox status in lung cancer patients is related to altered glucose metabolism. PLOS ONE 13:9, pages e0204173.
Crossref
Crossref
Jinpeng Cui, Yinghua Pan, Jianhua Wang, Yan Liu, Hongyan Wang & Hongyan Li. (2018) MicroRNA‑206 suppresses proliferation and predicts poor prognosis of HR‑HPV-positive cervical cancer cells by targeting G6PD. Oncology Letters.
Crossref
Crossref
Matteo Turetta, Michela Bulfoni, Giulia Brisotto, Gianpiero Fasola, Andrea Zanello, Eva Biscontin, Laura Mariuzzi, Agostino Steffan, Carla Di Loreto, Daniela Cesselli & Fabio Del Ben. (2018) Assessment of the Mutational Status of NSCLC Using Hypermetabolic Circulating Tumor Cells. Cancers 10:8, pages 270.
Crossref
Crossref